Publication Name	World Journal of Ophthalmology
Manuscript ID	17242
Country

Received	2015-02-26 09:30
Peer-Review Started	2015-02-26 18:15
To Make the First Decision	2015-04-10 16:42
Return for Revision	2015-04-15 10:30
Revised	2015-05-26 00:00
Second Decision	2015-06-08 11:36
Accepted by Journal Editor-in-Chief	2015-06-09 05:41
Accepted by Company Editor-in-Chief	2015-06-16 16:35
Articles in Press	2015-06-16 16:35
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-07-01 07:02
Typeset the Manuscript	2015-07-27 11:46
Publish the Manuscript Online	2015-08-17 11:09

ISSN	2218-6239 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Ophthalmology
Manuscript Type	Minireviews
Article Title	Intravitreal drug administration for treatment of noninfectious uveitis
Manuscript Source	Invited Manuscript
All Author List	Alper Yazici and Pinar C Ozdal
Funding Agency and Grant Number
Corresponding Author	Alper Yazici, MD, Assistant Professor, Department of Ophthalmology, Balıkesir University School of Medicine, 17. Km Bigadic Road, Cagis Campus Balikesir University Hospital, 10145 Balikesir, Turkey. lpryzc@yahoo.com
Key Words	Uveitis; Intravitreal; Steroid; Implant
Core Tip	The limitations related to the systemic use of treatment options in noninfectious posterior uveitis yielded intravitreal route. The hallmark of intravitreal treatment triamcinolone acetonide has a short half-life with a high rate of intraocular complications, and this led to the development of implants as a treatment option with various agents in the market still under investigation. In this review, we try to summarize the intravitreal therapeutic options that are being used in noninfectious uveitis.
Publish Date	2015-08-17 11:09
Citation	Yazici A, Ozdal PC. Intravitreal drug administration for treatment of noninfectious uveitis. World J Ophthalmol 2015; 5(3): 125-132
URL	http://www.wjgnet.com/2218-6239/full/v5/i3/125.htm
DOI	http://dx.doi.org/10.5318/wjo.v5.i3.125

Full Article (PDF)	WJO-5-125.pdf
Full Article (Word)	WJO-5-125.doc
Manuscript File	17242-Review.docx
Answering Reviewers	17242-Answering reviewers.pdf
Audio Core Tip	17242-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	17242-Conflict-of-interest statement.pdf
Copyright License Agreement	17242-Copyright assignment.pdf
Peer-review Report	17242-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	17242-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	17242-Scientific misconduct check.pdf
Scientific Editor Work List	17242-Scientific editor work list.pdf